SE9801516D0 - M100907/4-Piperidinemethanol derivatives for autism - Google Patents

M100907/4-Piperidinemethanol derivatives for autism

Info

Publication number
SE9801516D0
SE9801516D0 SE9801516A SE9801516A SE9801516D0 SE 9801516 D0 SE9801516 D0 SE 9801516D0 SE 9801516 A SE9801516 A SE 9801516A SE 9801516 A SE9801516 A SE 9801516A SE 9801516 D0 SE9801516 D0 SE 9801516D0
Authority
SE
Sweden
Prior art keywords
autism
methanol derivatives
piperidine methanol
compound
treatment
Prior art date
Application number
SE9801516A
Other languages
English (en)
Swedish (sv)
Inventor
Maria Carlsson
Original Assignee
Maria Carlsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Carlsson filed Critical Maria Carlsson
Priority to SE9801516A priority Critical patent/SE9801516D0/xx
Publication of SE9801516D0 publication Critical patent/SE9801516D0/xx
Priority to AU43016/99A priority patent/AU4301699A/en
Priority to AT99948543T priority patent/ATE236634T1/de
Priority to ES99948543T priority patent/ES2197675T3/es
Priority to EP99948543A priority patent/EP1082116B1/en
Priority to DK99948543T priority patent/DK1082116T3/da
Priority to JP2000546775A priority patent/JP2002513759A/ja
Priority to US09/674,095 priority patent/US6358977B1/en
Priority to PCT/SE1999/000683 priority patent/WO1999056750A1/en
Priority to NZ508422A priority patent/NZ508422A/en
Priority to PT99948543T priority patent/PT1082116E/pt
Priority to CA002330568A priority patent/CA2330568A1/en
Priority to DE69906728T priority patent/DE69906728T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9801516A 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism SE9801516D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9801516A SE9801516D0 (sv) 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism
DE69906728T DE69906728T2 (de) 1998-04-30 1999-04-26 Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
EP99948543A EP1082116B1 (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
AT99948543T ATE236634T1 (de) 1998-04-30 1999-04-26 Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ES99948543T ES2197675T3 (es) 1998-04-30 1999-04-26 Uso de derivados de 4-piperidinometanol en el tratamiento de trastornos del neurodesarrollo.
AU43016/99A AU4301699A (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
DK99948543T DK1082116T3 (da) 1998-04-30 1999-04-26 Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme
JP2000546775A JP2002513759A (ja) 1998-04-30 1999-04-26 神経発達障害の処置における４−ピペリジンメタノール誘導体の使用
US09/674,095 US6358977B1 (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
PCT/SE1999/000683 WO1999056750A1 (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
NZ508422A NZ508422A (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
PT99948543T PT1082116E (pt) 1998-04-30 1999-04-26 Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
CA002330568A CA2330568A1 (en) 1998-04-30 1999-04-26 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801516A SE9801516D0 (sv) 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism

Publications (1)

Publication Number Publication Date
SE9801516D0 true SE9801516D0 (sv) 1998-04-30

Family

ID=20411144

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801516A SE9801516D0 (sv) 1998-04-30 1998-04-30 M100907/4-Piperidinemethanol derivatives for autism

Country Status (13)

Country Link
US (1) US6358977B1 (xx)
EP (1) EP1082116B1 (xx)
JP (1) JP2002513759A (xx)
AT (1) ATE236634T1 (xx)
AU (1) AU4301699A (xx)
CA (1) CA2330568A1 (xx)
DE (1) DE69906728T2 (xx)
DK (1) DK1082116T3 (xx)
ES (1) ES2197675T3 (xx)
NZ (1) NZ508422A (xx)
PT (1) PT1082116E (xx)
SE (1) SE9801516D0 (xx)
WO (1) WO1999056750A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903187B1 (en) * 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
DE10212564B4 (de) 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
PT1534391E (pt) * 2002-07-19 2007-05-31 Biovitrum Ab Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
JP4646574B2 (ja) * 2004-08-30 2011-03-09 株式会社日立製作所 データ処理システム
WO2006077846A1 (ja) * 2005-01-18 2006-07-27 Mitsubishi Pharma Corporation 注意欠陥/多動性障害治療薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992546A (en) * 1973-10-18 1976-11-16 Ciba-Geigy Corporation 4-Piperidinobutyrophenones as neuroleptics
ZA864772B (en) * 1985-07-02 1987-02-25 Merrell Dow Pharma Novel chemical compounds
AU652759B2 (en) * 1990-06-01 1994-09-08 Aventisub Ii Inc. (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol
US5618824A (en) * 1994-03-09 1997-04-08 Merrell Pharmaceuticals Inc. Treatment of obsessive-compulsive disorders with 5-HT2 antagonists

Also Published As

Publication number Publication date
PT1082116E (pt) 2003-08-29
WO1999056750A1 (en) 1999-11-11
EP1082116A1 (en) 2001-03-14
AU4301699A (en) 1999-11-23
NZ508422A (en) 2002-05-31
DE69906728T2 (de) 2004-02-26
ES2197675T3 (es) 2004-01-01
DK1082116T3 (da) 2003-07-21
EP1082116B1 (en) 2003-04-09
DE69906728D1 (de) 2003-05-15
ATE236634T1 (de) 2003-04-15
CA2330568A1 (en) 1999-11-11
JP2002513759A (ja) 2002-05-14
US6358977B1 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
SE0104334D0 (sv) Therapeutic agents
MXPA01007940A (es) Derivados de azabicicloalcano y usos terapeuticos de los mismos.
NO942309L (no) 5-amino-8-methyl-7-pyrrolidinylkinolin-3-carboxylsyrederivater
SE9801516D0 (sv) M100907/4-Piperidinemethanol derivatives for autism
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
SE0104333D0 (sv) Therapeutic agents
DK36291D0 (da) Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
HU912901D0 (en) Method for producing 3-(1h-indazole-3-yl)-4-pyridine amines and pharmaceutical preparatives containing said compounds
SE9900190D0 (sv) New compounds
NO20020475D0 (no) 2-aminotetralinderivater for terapi av glaukom
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
MX9703712A (es) Derivados de 6-metoxi-1h-benzotriazol-5-carboxamida, sus procesos de produccion y las composiciones farmaceuticas que los contienen.
NO970431L (no) Tetrahydroisokinolin-derivater
AU5893398A (en) Pharmaceutical composition for the treatment of so-called restless legs
EE200100193A (et) 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises